Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,380,956
  • Shares Outstanding, K 50,298
  • Annual Sales, $ 988,480 K
  • Annual Income, $ 76,530 K
  • 60-Month Beta 0.69
  • Price/Sales 4.55
  • Price/Cash Flow 15.99
  • Price/Book 7.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.41
  • Number of Estimates 4
  • High Estimate 0.58
  • Low Estimate 0.32
  • Prior Year 0.81
  • Growth Rate Est. (year over year) -49.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
83.27 +4.60%
on 06/19/20
94.38 -7.71%
on 06/11/20
-9.13 (-9.49%)
since 06/10/20
3-Month
83.27 +4.60%
on 06/19/20
121.81 -28.49%
on 04/28/20
-13.36 (-13.30%)
since 04/09/20
52-Week
63.41 +37.36%
on 03/18/20
140.36 -37.95%
on 08/19/19
-33.96 (-28.05%)
since 07/10/19

Most Recent Stories

More News
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2021 Results: August 4, 2020

, /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish first quarter fiscal year 2021 financial results at 6:00 am EDT on . The Company will hold a conference...

HAE : 86.75 (-0.40%)
The Global Blood Bags Market is expected to grow from USD 312.18 Million in 2019 to USD 437.87 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.80%

, /PRNewswire/ --

FSNUF : 51.6544 (+1.20%)
HAE : 86.75 (-0.40%)
TRUMF : 37.3600 (+0.40%)
Haemonetics Announces 2020 Annual Meeting Of Shareholders Will Be Conducted In Virtual Format

, /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced that...

HAE : 86.75 (-0.40%)
Global blood bags market is forecast to grow at a CAGR of 10% during 2021-2025

, /PRNewswire/ -- Read the full report: Global blood bags market is forecast to grow at a CAGR of 10% during 2021-2025 owing to rising incidences of blood-related disorders and increasing number of...

FSNUF : 51.6544 (+1.20%)
HAE : 86.75 (-0.40%)
TFX : 355.18 (-0.50%)
TRUMF : 37.3600 (+0.40%)
Look for Shares of Haemonetics Corp to Potentially Rebound after Yesterday's 3.22% Sell Off

Haemonetics Corp (NYSE:HAE) traded in a range yesterday that spanned from a low of $95.86 to a high of $99.31. Yesterday, the shares fell 3.2%, which took the trading range below the 3-day low of $97.12...

HAE : 86.75 (-0.40%)
Here's Why You Should Hold on to Haemonetics Stock for Now

Investors continue to be optimistic about Haemonetics (HAE) on sustained underlying product demand and geographical expansion.

ILMN : 373.64 (+0.28%)
HAE : 86.75 (-0.40%)
QGEN : 44.82 (+0.61%)
APHA : 4.23 (+0.95%)
Haemonetics (HAE) Inks Deal With GVS for Blood Filter Supply

Haemonetics (HAE) inks deal to enhance operations and provide high quality products through an asset-lite approach in its blood filters operations.

ILMN : 373.64 (+0.28%)
HAE : 86.75 (-0.40%)
QGEN : 44.82 (+0.61%)
APHA : 4.23 (+0.95%)
Haemonetics Announces Blood Filter Supply Agreement And Sale Of Puerto Rico-Based Manufacturing Operations To GVS, S.p.A

, /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced that...

HAE : 86.75 (-0.40%)
Haemonetics Announces Sale Of U.S. Blood Donor Management Software Solution Assets To The GPI Group

, /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced that...

IM : 38.89 (+0.03%)
HAE : 86.75 (-0.40%)
The Global Platelet Aggregation Devices Market is expected to grow from USD 249.07 Million in 2018 to USD 713.73 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 16.22%

Reportlinker.com announces the release of the report "Global Platelet Aggregation Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts...

HAE : 86.75 (-0.40%)
SIEGY : 60.6400 (+1.15%)
SSMXY : 37.3600 (+0.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade HAE with:

Business Summary

Haemonetics Corporation is a Global Leader in Blood Management Solutions. Their comprehensive portfolio of devices, information management, consulting services offers blood management solutions for each facet of the blood supply chain from plasma blood collectors to hospitals. They believe that through...

See More

Key Turning Points

2nd Resistance Point 90.86
1st Resistance Point 88.98
Last Price 86.75
1st Support Level 86.05
2nd Support Level 85.00

See More

52-Week High 140.36
Fibonacci 61.8% 110.97
Fibonacci 50% 101.89
Fibonacci 38.2% 92.80
Last Price 86.75
52-Week Low 63.41

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar